Rating History for Amylin Pharmaceuticals (AMLN) by BMO Capital

More Stocks Rated by BMO Capital | Latest Ratings for AMLN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/2/2012 N/A Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 28.20
(30.98)		 9.86% Details